Targeting S100A9-ALDH1A1-Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer

Using metastatic models of EGFR-mutant lung cancer, the authors showed that cancer cells expressing high intracellular S100A9 escaped osimertinib and initiated brain relapses.